+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Epigenetics Market Size, Share & Analysis By Product, By Technology, By Application, By End-Use, And By Region, Forecast To 2028

  • PDF Icon

    Report

  • 127 Pages
  • April 2021
  • Region: Global
  • Reports and Data
  • ID: 5312330
Prevalence of various types of cancer, coupled with rising need for advanced cancer treatment and drugs are key factors driving market revenue growth.

Market Size - USD 9,143.1 Million in 2020, Market Growth - CAGR of 18.8%, Market Trends - Increasing research and development to explore novel treatment for cancer.

The global epigenetic market size is expected to reach USD 36.52 Billion in 2028, and register a CAGR of 18.8% during the forecast period. Rising number of deaths by cancer, global geriatric population globally, and rising awareness regarding need for epigenetic are factors expected to drive market growth. According to a report by World Health Organization, number of cancer patients is going to increase to 19.3 Million by 2025 globally.

High cost of instruments required for epigenetics research and maintenance are factors that could hamper market growth to some extent.

Some Key Findings From the Report:
  • Among the product segments, the reagents segment accounted for major revenue share in 2020. The kits segment is expected to register the highest revenue growth rate during the forecast period. Ready-to-use kits are in high demand for detection of epigenetic modifications.
  • Among the technology segments, the DNA methylation segment accounted for the largest revenue share of 36.3% in 2020. The histone acetylation segment is expected to register the highest revenue growth rate during the forecast period, owing to its enhanced efficacy due to development of novel mechanisms.
  • Among the application segments, the oncology segment accounted for the largest revenue share in the global epigenetics market in 2020. Rising number of cancer patients globally and increasing research and development for offering novel drugs and treatment is supporting revenue growth of this segment.
  • North America market accounted for the largest revenue share in the global epigenetics market in 2020, due to increasing initiative by governments in countries in the region to encourage research on epigenetics and strong presence of major players in the region

.
  • The Asia Pacific market size was USD 2,011.5 Million in 2020, due to increasing medical tourism and rapidly increasing investments for research and development in the field.
  • Some of the prominent players in the market include Illumina, Thermo Fisher Scientific, Merck Millipore, Abcam, Active Motif, Bio-Rad Laboratories, New England Biolabs, Agilent, QIAGEN, Zymo Research, PerkinElmer, and Diagenode. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.

For the purpose of this report, the global epigenetics market is segmented on the basis of product, technology, application, end use, and region:

Product Outlook
  • Reagents
  • Kits
  • Chip sequencing kit
  • Whole Genomic Amplification kit
  • Bisulfite Conversion kit
  • RNA sequencing kit
  • Others
  • Instruments
  • Enzymes
  • Services

Technology Outlook
  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large non - coding RNA
  • MicroRNA modification
  • Chromatin structures

Application Outlook
  • Oncology
  • Solid tumors
  • Liquid tumors
  • Non - oncology
  • Inflammatory diseases
  • Metabolic diseases
  • Infectious diseases
  • Cardiovascular diseases
  • Others

End Use Outlook
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)

Region Outlook
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Benelux
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

Reasons to Buy the Report
  • A robust analysis and estimation of the Epigenetics Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
  • A holistic competitive landscape of all the major players in the Epigenetics Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
  • Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
  • Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
  • Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization

Table of Contents

Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2020 - 2028
Chapter 3. Indicative Metrics
3.1. Increasing geriatric population
3.2. Rising prevalence of cancer
3.3. Reducing sequencing time
Chapter 4. Epigenetics Segmentation & Impact Analysis
4.1. Epigenetics Segmentation Analysis
4.2. Epigenetics Market Value Chain Analysis, 2018 - 2028
4.3. Regulatory framework
4.4. Epigenetics Market Impact Analysis
4.4.1. Market driver analysis
4.4.1.1. Increasing research activities in epigenetics
4.4.1.2. Need for personalized health care
4.4.2. Market restraint analysis
4.4.2.1. High initial and maintenance cost
4.4.2.2. Concerns regarding quality of antibodies
4.5. Key opportunities prioritized
4.6. Epigenetics Pricing Analysis
4.7. Industry analysis - Porter's
4.8. Epigenetics PESTEL Analysis
Chapter 5. Epigenetics Market By Product Type Insights & Trends
5.1. Epigenetics Product Type dynamics & Market Share, 2021 & 2028
5.2. Reagents
5.2.1. Market estimates and forecast, 2018 - 2028 (USD Million)
5.2.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
5.3. Kits
5.3.1. Market estimates and forecast, 2018 - 2028 (USD Million)
5.3.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
5.3.3. Chip Sequencing Kit
5.3.3.1. Market estimates and forecast, 2018 - 2028 (USD Million)
5.3.3.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
5.3.4. Whole Genomic Amplification Kit
5.3.4.1. Market estimates and forecast, 2018 - 2028 (USD Million)
5.3.4.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
5.3.5. Bisulfite Conversion Kit
5.3.5.1. Market estimates and forecast, 2018 - 2028 (USD Million)
5.3.5.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
5.3.6. RNA Sequencing Kit
5.3.6.1. Market estimates and forecast, 2018 - 2028 (USD Million)
5.3.6.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
5.3.7. Others
5.3.7.1. Market estimates and forecast, 2018 - 2028 (USD Million)
5.3.7.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
5.4. Instruments
5.4.1. Market estimates and forecast, 2018 - 2028 (USD Million)
5.4.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
5.5. Enzymes
5.5.1. Market estimates and forecast, 2018 - 2028 (USD Million)
5.5.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
5.6. Services
5.6.1. Market estimates and forecast, 2018 - 2028 (USD Million)
5.6.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
Chapter 6. Epigenetics Market By Technology Insights & Trends
6.1. Epigenetics Technology dynamics & Market Share, 2021 & 2028
6.2. DNA Methylation
6.2.1. Market estimates and forecast, 2018 - 2028 (USD Million)
6.2.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
6.3. Histone Methylation
6.3.1. Market estimates and forecast, 2018 - 2028 (USD Million)
6.3.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
6.4. Histone Acetylation
6.4.1. Market estimates and forecast, 2018 - 2028 (USD Million)
6.4.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
6.5. Large non-coding RNA
6.5.1. Market estimates and forecast, 2018 - 2028 (USD Million)
6.5.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
6.6. Micro-RNA modifications
6.6.1. Market estimates and forecast, 2018 - 2028 (USD Million)
6.6.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
6.7. Chromatin Structures
6.7.1. Market estimates and forecast, 2018 - 2028 (USD Million)
6.7.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
Chapter 7. Epigenetics Market By Application Insights & Trends
7.1. Epigenetics Application dynamics & Market Share, 2021 & 2028
7.2. Oncology
7.2.1. Market estimates and forecast, 2018 - 2028 (USD Million)
7.2.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
7.2.3. Solid Tumors
7.2.3.1. Market estimates and forecast, 2018 - 2028 (USD Million)
7.2.3.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
7.2.4. Liquid Tumors
7.2.4.1. Market estimates and forecast, 2018 - 2028 (USD Million)
7.2.4.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
7.3. Non-oncology
7.3.1. Market estimates and forecast, 2018 - 2028 (USD Million)
7.3.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
7.3.3. Inflammatory diseases
7.3.3.1. Market estimates and forecast, 2018 - 2028 (USD Million)
7.3.3.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
7.3.4. Metabolic diseases
7.3.4.1. Market estimates and forecast, 2018 - 2028 (USD Million)
7.3.4.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
7.3.5. Infectious diseases
7.3.5.1. Market estimates and forecast, 2018 - 2028 (USD Million)
7.3.5.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
7.3.6. Cardio-vascular diseases
7.3.6.1. Market estimates and forecast, 2018 - 2028 (USD Million)
7.3.6.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
7.3.7. Others
7.3.7.1. Market estimates and forecast, 2018 - 2028 (USD Million)
7.3.7.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
Chapter 8. Epigenetics Market By End-Use Insights & Trends
8.1. Epigenetics End-Use dynamics & Market Share, 2021 & 2028
8.2. Academic and Research institutes
8.2.1. Market estimates and forecast, 2018 - 2028 (USD Million)
8.2.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
8.3. Pharmaceutical and Biotechnology Companies
8.3.1. Market estimates and forecast, 2018 - 2028 (USD Million)
8.3.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
8.4. Contract Research Organizations
8.4.1. Market estimates and forecast, 2018 - 2028 (USD Million)
8.4.2. Market estimates and forecast, by region, 2018 - 2028 (USD Million)
Chapter 9. Epigenetics Market Regional Outlook
9.1. Epigenetics Market share by region, 2021 & 2028
9.2. North America
9.2.1. North America Epigenetics Market estimates and forecast, 2018 - 2028, (USD Million)
9.2.2. North America Epigenetics Market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.2.3. North America Epigenetics Market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.2.4. North America Epigenetics Market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.2.5. North America Epigenetics Market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.2.6. U.S.
9.2.6.1. U.S. Epigenetics Market estimates and forecast, 2018 - 2028, (USD Million)
9.2.6.2. U.S. Epigenetics Market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.2.6.3. U.S. Epigenetics Market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.2.6.4. U.S. Epigenetics Market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.2.6.5. U.S. Epigenetics Market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.2.7. Canada
9.2.7.1. Canada Epigenetics Market estimates and forecast, 2018 - 2028, (USD Million)
9.2.7.2. Canada Epigenetics Market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.2.7.3. Canada Epigenetics Market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.2.7.4. Canada Epigenetics Market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.2.7.5. Canada Epigenetics Market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.3. Europe
9.3.1. Europe Epigenetics Market estimates and forecast, 2018 - 2028, (USD Million)
9.3.2. Europe Epigenetics Market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.3.3. Europe Epigenetics Market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.3.4. Europe Epigenetics Market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.3.5. Europe Epigenetics Market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.3.6. Germany
9.3.6.1. Germany Epigenetics Market estimates and forecast, 2018 - 2028, (USD Million)
9.3.6.2. Germany Epigenetics Market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.3.6.3. Germany Epigenetics market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.3.6.4. Germany Epigenetics market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.3.6.5. Germany Epigenetics market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.3.7. France
9.3.7.1. France Epigenetics Market estimates and forecast, 2018 - 2028, (USD Million)
9.3.7.2. France Epigenetics Market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.3.7.3. France Epigenetics market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.3.7.4. France Epigenetics market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.3.7.5. France Epigenetics market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.3.8. U.K.
9.3.8.1. U.K Epigenetics market estimates and forecast, 2018 - 2028, (USD Million)
9.3.8.2. U.K Epigenetics market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.3.8.3. U.K. Epigenetics market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.3.8.4. U.K. Epigenetics market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.3.8.5. U.K. Epigenetics market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.3.9. Spain
9.3.9.1. Spain Epigenetics market estimates and forecast, 2018 - 2028, (USD Million)
9.3.9.2. Spain Epigenetics market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.3.9.3. Spain. Epigenetics market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.3.9.4. Spain Epigenetics market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.3.9.5. Spain Epigenetics market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.3.10. Italy
9.3.10.1. Italy Epigenetics Market estimates and forecast, 2018 - 2028, (USD Million)
9.3.10.2. Italy Epigenetics Market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.3.10.3. Italy Epigenetics market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.3.10.4. Italy Epigenetics market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.3.10.5. Italy Epigenetics market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.3.11. Rest of Europe
9.3.11.1. Rest of Europe Epigenetics market estimates and forecast, 2018 - 2028, (USD Million)
9.3.11.2. Rest of Europe Epigenetics market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.3.11.3. Rest of Europe Epigenetics market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.3.11.4. Rest of Europe Epigenetics market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.3.11.5. Rest of Europe Epigenetics market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Epigenetics market estimates and forecast, 2018 - 2028, (USD Million)
9.4.2. Asia Pacific Epigenetics market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.4.3. Asia Pacific Epigenetics market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.4.4. Asia Pacific Epigenetics market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.4.5. Asia Pacific Epigenetics market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.4.6. China
9.4.6.1. China Epigenetics market estimates and forecast, 2018 - 2028, (USD Million)
9.4.6.2. China Epigenetics market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.4.6.3. China Epigenetics market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.4.6.4. China Epigenetics market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.4.6.5. China Epigenetics market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.4.7. Japan
9.4.7.1. Japan Epigenetics market estimates and forecast, 2018 - 2028, (USD Million)
9.4.7.2. Japan Epigenetics market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.4.7.3. Japan Epigenetics market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.4.7.4. Japan Epigenetics market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.4.7.5. Japan Epigenetics market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.4.8. India
9.4.8.1. India Epigenetics market estimates and forecast, 2018 - 2028, (USD Million)
9.4.8.2. India Epigenetics market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.4.8.3. India Epigenetics market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.4.8.4. India Epigenetics market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.4.8.5. India Epigenetics market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.4.9. Rest of Asia Pacific
9.4.9.1. Rest of Asia Pacific Epigenetics market estimates and forecast, 2018 - 2028, (USD Million)
9.4.9.2. Rest of Asia Pacific Epigenetics market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.4.9.3. Rest of Asia Pacific Epigenetics market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.4.9.4. Rest of Asia Pacific Epigenetics market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.4.9.5. Rest of Asia Pacific Epigenetics market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.5. Middle East & Africa
9.5.1. Middle East and Africa Epigenetics market estimates and forecast, 2018 - 2028, (USD Million)
9.5.2. Middle East and Africa Epigenetics market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.5.3. Middle East and Africa Epigenetics market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.5.4. Middle East and Africa Epigenetics market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.5.5. Middle East and Africa Epigenetics market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.6. Latin America
9.6.1. Latin America Epigenetics market estimates and forecast, 2018 - 2028, (USD Million)
9.6.2. Latin America Epigenetics market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.6.3. Latin America Epigenetics market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.6.4. Latin America Epigenetics market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.6.5. Latin America Epigenetics market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
9.6.6. Brazil
9.6.6.1. Brazil Epigenetics market estimates and forecast, 2018 - 2028, (USD Million)
9.6.6.2. Brazil Epigenetics market estimates and forecast by Product Type, 2018 - 2028, (USD Million)
9.6.6.3. Brazil Epigenetics market estimates and forecast by Technology, 2018 - 2028, (USD Million)
9.6.6.4. Brazil Epigenetics market estimates and forecast by Application, 2018 - 2028, (USD Million)
9.6.6.5. Brazil Epigenetics market estimates and forecast by End-Use, 2018 - 2028, (USD Million)
Chapter 10. Competitive Landscape
10.1. Market Revenue Share by Manufacturers
10.2. Manufacturing Cost Breakdown Analysis
10.3. Mergers & Acquisitions
10.4. Strategy Benchmarking
10.5. Vendor Landscape
Chapter 11. Company Profiles
11.1. Illumina
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Length Benchmarking
11.1.4. Strategic Initiatives
11.2. Thermo Fisher Scientific
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Length Benchmarking
11.2.4. Strategic Initiatives
11.3. Merck Millipore
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Length Benchmarking
11.3.4. Strategic Initiatives
11.4. Abcam
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Length Benchmarking
11.4.4. Strategic Initiatives
11.5. Active Motif
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Length Benchmarking
11.5.4. Strategic Initiatives
11.6. Bio-Rad Laboratories
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Length Benchmarking
11.6.4. Strategic Initiatives
11.7. New England Biolabs
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Length Benchmarking
11.7.4. Strategic Initiatives
11.8. Agilent
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Length Benchmarking
11.8.4. Strategic Initiatives
11.9. QIAGEN
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Length Benchmarking
11.9.4. Strategic Initiatives
11.10. Zymo Research
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Length Benchmarking
11.10.4. Strategic Initiatives

Companies Mentioned

  • Illumina (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • Merck Millipore (U.S.)
  • Abcam (U.K.)
  • Active Motif (U.S.)
  • Bio-Rad Laboratories (U.S.)
  • New England Biolabs (U.S.)
  • Agilent (U.S.)
  • QIAGEN (Netherlands)
  • Zymo Research (U.S.)
  • PerkinElmer (U.S.)
  • Diagenode (Belgium).